Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
LSP Bioventures
AddedMar 19, 2024
UpdatedJun 28, 2026
LSP Bioventures

LSP Bioventures

Operating

Global investment in healthcare & life sciences sectors by Life Sciences Partners B.V. Serving US, Netherlands, Germany.

Location
Amsterdam, North Holland, NL
Founded
2006
Firm
Compare
Portfolio
Employees
Website

LSP Bioventures - Website

An index of every page on lspvc.com, by section.

13 pages across 4 sections · Updated Jul 16, 2026·

Homepage

LSP Bioventures's front door: current positioning and top-line messaging.

eqtgroup.com

BlogSee all

Product updates, deep-dives, and company thinking: LSP Bioventures's 5-post archive.

eqtgroup.com/news
  • April 7, 2026EQT Life Sciences to exit minority stake in Tubulis via sale to Gilead Sciences for up to USD 5.0 billionoff-site
  • January 12, 2026EQT Life Sciences backs Kinaset Therapeutics’ USD103 million Series B to advance inhaled therapeutic for treatment of respiratory diseasesoff-site
  • January 12, 2026EQT Life Sciences to exit Vivasure Medical via sale to Haemoneticsoff-site
  • October 22, 2025EQT Life Sciences Co-Leads USD 183 Million Series C Financing in Electra Therapeuticsoff-site

TermsTerms and Conditions of Use

The legal agreement governing use of LSP Bioventures's products and services.

eqtgroup.com/terms-and-conditions

AboutExplore more companies

Company story, mission, and background as LSP Bioventures tells it.

eqtgroup.com/about/current-portfolio
  • See full teamoff-site/about/people
  • Officesoff-site/about/offices
  • Careers at EQToff-site/about/careers
  • See company pageoff-site
  • See company pageoff-site/about/current-portfolio/neuravi